ALKBH4 functions as a hypoxia-responsive tumor suppressor and inhibits metastasis and tumorigenesis.
- Published in:
- Cellular Oncology (2211-3428), 2025, v. 48, n. 2, p. 425, doi. 10.1007/s13402-024-01004-x
- By:
- Publication type:
- Article
Works by Peng, Pei‐Hua
Results: 14
1
2
Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-79337-4
- By:
- Publication type:
- Article
3
Targeting interleukin-17 receptor B enhances gemcitabine sensitivity through downregulation of mucins in pancreatic cancer.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-73659-z
- By:
- Publication type:
- Article
4
Chromatin accessibility analysis identifies GSTM1 as a prognostic marker in human glioblastoma patients.
- Published in:
- Clinical Epigenetics, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13148-021-01181-8
- By:
- Publication type:
- Article
5
Scutellarin Reduces Cerebral Ischemia Reperfusion Injury Involving in Vascular Endothelium Protection and PKG Signal.
- Published in:
- Natural Products & Bioprospecting, 2021, v. 11, n. 6, p. 659, doi. 10.1007/s13659-021-00322-z
- By:
- Publication type:
- Article
6
METTL4-mediated nuclear N6-deoxyadenosine methylation promotes metastasis through activating multiple metastasis-inducing targets.
- Published in:
- Genome Biology, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s13059-022-02819-3
- By:
- Publication type:
- Article
7
Interplay between lncRNA RP11-367G18.1 variant 2 and YY1 plays a vital role in hypoxia-mediated gene expression and tumorigenesis.
- Published in:
- Cancer Cell International, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12935-023-03067-6
- By:
- Publication type:
- Article
8
Identification of candidate nasopharyngeal carcinoma serum biomarkers by cancer cell secretome and tissue transcriptome analysis: Potential usage of cystatin A for predicting nodal stage and poor prognosis.
- Published in:
- Proteomics, 2010, v. 10, n. 14, p. 2644, doi. 10.1002/pmic.200900620
- By:
- Publication type:
- Article
9
Identification of potential serum markers for nasopharyngeal carcinoma from a xenografted mouse model using Cy-dye labeling combined with three-dimensional fractionation.
- Published in:
- Proteomics, 2008, v. 8, n. 17, p. 3605, doi. 10.1002/pmic.200701034
- By:
- Publication type:
- Article
10
Identification of secretory gelsolin as a plasma biomarker associated with distant organ metastasis of colorectal cancer.
- Published in:
- Journal of Molecular Medicine, 2012, v. 90, n. 2, p. 187, doi. 10.1007/s00109-011-0817-4
- By:
- Publication type:
- Article
11
RP11‐367G18.1 V2 enhances clear cell renal cell carcinoma progression via induction of epithelial–mesenchymal transition.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 8, p. 9788, doi. 10.1002/cam4.5723
- By:
- Publication type:
- Article
12
Epigenetic regulation of asymmetric cell division by the LIBR-BRD4 axis.
- Published in:
- Nucleic Acids Research, 2024, v. 52, n. 1, p. 154, doi. 10.1093/nar/gkad1095
- By:
- Publication type:
- Article
13
Integration of the cancer cell secretome and transcriptome reveals potential noninvasive diagnostic markers for bladder cancer.
- Published in:
- Proteomics - Clinical Applications, 2024, v. 18, n. 4, p. 1, doi. 10.1002/prca.202300033
- By:
- Publication type:
- Article
14
Identification of candidate nasopharyngeal carcinoma serum biomarkers by cancer cell secretome and tissue transcriptome analysis: Potential usage of cystatin A for predicting nodal stage and poor prognosis.
- Published in:
- Proteomics - Clinical Applications, 2010, v. 4, n. 10/11, p. 857, doi. 10.1002/prca.201090074
- By:
- Publication type:
- Article